We are live on !
Find out more
Callan Capital Portfolio holdings
AUM
$1.35B
Turnover
17.35%
1-Year Est. Return
8.35%
This Fund
S&P 500
This Quarter Est. Return
+2.13%
1 Year Est. Return
+8.35%
3 Year Est. Return
+20.11%
5 Year Est. Return
+98.58%
10 Year Est. Return
+95.87%
AUM
$1.22B
AUM Growth
+$77.6M
(+6.8%)
Cap. Flow
+$59.9M
Cap. Flow % of AUM
Cap. Flow %
4.93%
Top 10 Holdings %
Top 10 Hldgs %
46.33%
Holding
332
New
35
Increased
189
Reduced
69
Closed
18
Avg Time Held
Equity + Options
2.2
years
Top 10 Avg Time Held
Equity + Options
3.2
years
Top 20 Avg Time Held
Equity + Options
4
years
Avg Time Held Equity only
2.2
years
Top 10 Avg Time Held Equity only
3.2
years
Top 20 Avg Time Held Equity only
4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$18.4M |
| 2 |
Neumora Therapeutics
NMRA
|
+$4.72M |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$3.83M |
| 4 |
Avantis US Small Cap Value ETF
AVUV
|
+$3.67M |
| 5 |
iShares S&P 500 Growth ETF
IVW
|
+$3.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$1.96M |
| 2 |
Goldman Sachs ActiveBeta International Equity ETF
GSIE
|
+$906K |
| 3 |
iShares International Equity Factor ETF
INTF
|
+$852K |
| 4 |
Avantis US Equity ETF
AVUS
|
+$644K |
| 5 |
Dimensional International Small Cap Value ETF
DISV
|
+$589K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.41% |
| 2 | Technology | 7.75% |
| 3 | Healthcare | 2.78% |
| 4 | Financials | 1.79% |
| 5 | Communication Services | 1.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
126
Chevron
CVX
$441B
| $775K | 0.06% |
4,953
+2,541
| +105% | +$405K |
2024 Q1
1 quarter
|
|
127
Vanguard Morningstar Value ETF
VTV
$191B
| $765K | 0.06% |
4,772
| – | – |
2023 Q3
3 quarters
|
|
128
Schwab US Large-Cap Growth ETF
SCHG
$62.8B
| $752K | 0.06% |
29,824
+10,144
| +52% | +$239K |
2023 Q2
4 quarters
|
|
129
Biogen
BIIB
$34.4B
| $747K | 0.06% |
3,221
+180
| +6% | +$39.1K |
2022 Q4
6 quarters
|
|
130
Vanguard Total World Stock ETF
VT
$81.3B
| $723K | 0.06% |
6,422
+416
| +7% | +$45.9K |
2022 Q4
6 quarters
|
|
131
Caterpillar
CAT
$336B
| $717K | 0.06% |
2,152
+602
| +39% | +$209K |
2022 Q4
6 quarters
|
|
132
W.W. Grainger
GWW
$62.7B
| $712K | 0.06% |
789
-1
| -0.1% | -$941 |
2022 Q4
6 quarters
|
|
133
TotalEnergies
TTE
$201B
| $708K | 0.06% |
10,614
+3,575
| +51% | +$254K |
2023 Q4
2 quarters
|
|
134
iPath Select MLP ETN
ATMP
$623M
| $707K | 0.06% |
+28,186
| New | +$686K |
2024 Q2
0 quarters
|
|
135
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.68B
| $674K | 0.06% |
+9,357
| New | +$656K |
2024 Q2
0 quarters
|
|
136
BHP
BHP
$212B
| $668K | 0.06% |
11,706
+2,208
| +23% | +$128K |
2023 Q4
2 quarters
|
|
137
Abbott
ABT
$181B
| $657K | 0.05% |
6,327
+1,682
| +36% | +$178K |
2022 Q4
6 quarters
|
|
138
Visa
V
$756B
| $640K | 0.05% |
2,438
+209
| +9% | +$57.3K |
2023 Q3
3 quarters
|
|
139
Invesco S&P 500 Equal Weight ETF
RSP
$97.8B
| $635K | 0.05% |
+3,867
| New | +$636K |
2024 Q2
0 quarters
|
|
140
St. Joe Company
JOE
$3.89B
| $633K | 0.05% |
+11,575
| New | +$652K |
2024 Q2
0 quarters
|
|
141
Nomura Holdings
NMR
$27B
| $617K | 0.05% |
106,773
+13,654
| +15% | +$80.9K |
2023 Q4
2 quarters
|
|
142
Accenture
ACN
$141B
| $609K | 0.05% |
2,007
+218
| +12% | +$66.8K |
2022 Q3
7 quarters
|
|
143
Advanced Micro Devices
AMD
$863B
| $594K | 0.05% |
3,662
+325
| +10% | +$52.3K |
2023 Q3
3 quarters
|
|
144
Texas Instruments
TXN
$252B
| $586K | 0.05% |
3,011
+727
| +32% | +$134K |
2020 Q1
17 quarters
|
|
145
Trane Technologies
TT
$101B
| $585K | 0.05% |
1,777
+53
| +3% | +$16.9K |
2022 Q4
6 quarters
|
|
146
Lowe's Companies
LOW
$111B
| $584K | 0.05% |
2,649
-79
| -3% | -$18K |
2022 Q3
7 quarters
|
|
147
Walt Disney
DIS
$191B
| $564K | 0.05% |
5,679
+40
| +0.7% | +$4.31K |
2020 Q1
17 quarters
|
|
148
RTX Corp
RTX
$261B
| $548K | 0.05% |
5,458
+1,346
| +33% | +$139K |
2021 Q4
10 quarters
|
|
149
Invesco FTSE RAFI Developed Markets ex-US Small-Mid ETF
PDN
$345M
| $546K | 0.04% |
16,881
| – | – |
2021 Q4
10 quarters
|
|
150
Illinois Tool Works
ITW
$77.5B
| $544K | 0.04% |
2,294
+187
| +9% | +$46.2K |
2022 Q4
6 quarters
|
|
Similar funds
Callan Capital's Q2 2024 Portfolio in Review
As of Q2 2024, Callan Capital held 332 positions worth $1.22B, up 6.8% from $1.14B the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Callan Capital deployed $59.9M of net new capital in Q2 2024, opening 35 new positions and adding to 189 existing holdings. Its largest new stake was iShares Core S&P Mid-Cap ETF: 65,165 shares worth $3.81M.
By sector, the portfolio is most concentrated in Miscellaneous at 82% of assets, down from 86% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Vanguard Tax-Exempt Bond Index Fund, an estimated $1.96M trimmed.
- Callan Capital's largest Q2 2024 buy was iShares Core S&P Mid-Cap ETF: 65,165 shares worth $3.81M.
- Callan Capital added most to NVIDIA in Q2 2024, an estimated $18.4M increase.
- Callan Capital's biggest Q2 2024 reduction was Vanguard Tax-Exempt Bond Index Fund, cutting an estimated $1.96M.
- Callan Capital fully exited Takeda Pharmaceutical in Q2 2024, selling an estimated $354K.
- Callan Capital's ten largest holdings make up 46% of its $1.22B portfolio in Q2 2024.
- Callan Capital opened 35 new positions and closed 18 in Q2 2024.
- Callan Capital's portfolio value rose 6.8% quarter-over-quarter to $1.22B.
Based on Callan Capital's 13F filing for Q2 2024, filed 12 Aug 2024.